Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,802,084
-
Share change
-
+183,766
-
Total reported value
-
$294,301,994
-
Price per share
-
$61.27
-
Number of holders
-
112
-
Value change
-
+$11,647,620
-
Number of buys
-
60
-
Number of sells
-
49
Institutional Holders of BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) as of Q2 2020
As of 30 Jun 2020,
BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,802,084 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., Russell Investments Group, Ltd., RICE HALL JAMES & ASSOCIATES, LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, JANUS HENDERSON GROUP PLC, STATE STREET CORP, ROYCE & ASSOCIATES LP, and WELLS FARGO & COMPANY/MN.
This page lists
112
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.